Filing Details
- Accession Number:
- 0001209191-17-038418
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-07 18:59:32
- Reporting Period:
- 2017-06-05
- Filing Date:
- 2017-06-07
- Accepted Time:
- 2017-06-07 18:59:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1396814 | Pacira Pharmaceuticals Inc. | PCRX | Pharmaceutical Preparations (2834) | 510619477 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1545439 | Bullaro Lauren Riker | C/O Pacira Pharmaceuticals, Inc. 5 Sylvan Way, Suite 300 Parsippany NJ 07054 | Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-06-05 | 601 | $43.32 | 8,182 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- Includes 330 shares of common stock acquired under the issuer's employee stock purchase plan in June 2016.